Mushrooms have been used as a primary source of medicines since ancient times due to
the presence of bioactive compounds. Enzyme inhibition is an important field of …

As a continuation of our search for biologically active mushroom species the present study
investigates in vitro antidiabetic properties of six edible and medicinal mushroom species …

In Asia, medicinal mushrooms have been popularly used as folk medicine and functional
foods. In this study, our aim was to examine the inhibitory effects of six medicinal mushrooms …

Mushrooms belong to the family “Fungi” and became famous for their medicinal properties
and easy accessibility all over the world. Because of its pharmaceutical properties, including …

Objective: The present investigation comprises, in vitro antidiabetic activity such as α-
amylase and α-glucosidase inhibitory activities and in vivo antidiabetic activity of methanolic …

Management of type 2 diabetes by delaying or preventing glucose absorption using natural
products is gaining significant attention. Edible mushrooms are well documented for their …

Context: There has been enormous interest in the development of alternative medicines for
the control of diabetes. Use of carbohydrate-hydrolyzing enzyme inhibitors proved to be an …

Diabetes is a major health problem predisposing to markedly increased complications.
Despite the numerous preventative strategies and armories of medication, the management …

One of the antidiabetic therapeutic approaches is the reduction in gastrointestinal glucose
production and absorption by inhibiting carbohydrate hydrolyzing enzymes such as alpha …

Background α-Amylase catalyses the hydrolysis of starch and ultimately producing glucose.
Controlling the catalytic activity of this enzyme reduces glucose production in the …